| Literature DB >> 31489005 |
Afrasyab Altaf1, Hammad Shah2, Momin Salahuddin3.
Abstract
OBJECTIVE: There is very limited data about gender based differences in Acute Coronary Syndrome (ACS) in Asian population. This study was therefore aimed to ascertain gender based differences in clinical and angiographic characteristics and clinical outcomes in patient admitted with ACS.Entities:
Keywords: Acute Coronary Syndrome; Angiographic characteristics; Clinical Outcomes; Gender
Year: 2019 PMID: 31489005 PMCID: PMC6717489 DOI: 10.12669/pjms.35.5.743
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Baseline characteristics of study group.
| Variable | Male (n=210) | Female (n = 176) | P-value |
|---|---|---|---|
| Age(Years) | |||
| Body Mass Index(kg/m2) | 66.8±11.2 | 72.8±12.9 | |
| Population | 24.8 | 25.8 | |
| Rural | 126(60%) | 99(56.3%) | |
| Urban | 84(40%) | 77(43.8%) | |
| Diabetes | 65(31%) | 67(38.1%) | |
| Hypertension | 88(41.9%) | 72(40.9%) | |
| Hyperlipidemia | 47(22.3%) | 32(18.2%) | |
| Smoking | 101(48.1%) | 5(0.3%) | 0.046 |
| Ejection Fraction | 38.2±8.68 | 43.9±7.9 | 0.071 |
| NYHA Class | 2.9±1.2 | 3.1±1.6 | 0.066 |
| Hospital Stay(days) | 2.4±1.5 | 3.1±1.9 | 0.077 |
| Heart Failure | 36(17.1%) | 32(18.2%) | 0.024 |
| In hospital Treatment | 0.088 | ||
| Aspirin | 197(93.8%) | 159(90.3%) | 0.066 |
| Clopidogrel | 188(89.5%) | 162(92%) | <0.01 |
| Beta Blockers | 174(82.8%) | 141(80.1%) | 0.044 |
| CCBs | 17(8.1%) | 11(6.2%) | 0.063 |
| Digoxin | 30(14.3%) | 20(11.4%) | 0.061 |
| Ivabradine | 80(38.1%) | 58((32.9%) | 0.091 |
| ACEI | 166(79%) | 134(76.1%) | |
| ARBs | 132(62.8%) | 105(59.6%) | |
| Statins | 185(88.1%) | 144(81.6%) | |
| Ionotropes | 84(40%) | 58(32.9%) | |
| Enoxaparin | 193(91.9%) | 157(89.2%) | |
| Heparin | 16(7.6%) | 9(5.1%) | |
| Tirofiban | 9(4.3%) | 11(6.2%) | |
| Rivaroxeban | 12(5.7%) | 8(4.5%) |
Fig.1ACS outcomes in male and female patients.
Coronary Angiography Characteristics and Procedure Outcomes in ACS.
| Variable | Male (n=120) | Female (n =66) | P-value |
|---|---|---|---|
| Radial Approach | 79(65.8%) | 46(69.7%) | 0.063 |
| Femoral Approach | 41(34.2%) | 20(30.3%) | 0.071 |
| SVCAD | 25(20.8%) | 15(22.7%) | 0.083 |
| DVCAD | 30(25%) | 18(27.3%) | 0.061 |
| TVCAD | 63(52.5%) | 37(56.1%) | 0.058 |
| LMS Disease | 17(14.2%) | 9(13.6%) | 0.066 |
| LAD Disease | 98(81.7%) | 56(84.8%) | 0.081 |
| RCA Disease | 76(63.3%) | 42(63.6%) | 0.099 |
| Circumflex Disease | 88(73.3%) | 50(75.8%) | 0.061 |
| Single vessel PCI | 68(54.2%) | 29(43.9%) | 0.033 |
| Multi Vessel PCI | 57(47.5%) | 28(42.5%) | 0.041 |
| POBA Only | 2(1.7%) | 2(3%) | 0.089 |
| Hematoma Formation | 6(5%) | 4(6%) | 0.073 |
| Blood Transfusions | 1(0.8%) | 1(1.5%) | 0.066 |